Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Ravindran

Showing results (241-250 of 252) with videos related to

Pageof 26
Sort By:
Psychological Medicine|November 5, 2020
Mental health services for infectious disease outbreaks including COVID-19: a rapid systematic reviewJing-Li Yue, Wei Yan, Yan-Kun Sun, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|November 11, 2020
The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Recommendations for the Use of Racemic Ketamine in Adults with Major Depressive Disorder: Recommandations Du Groupe De Travail Du Réseau Canadien Pour Les Traitements De L'humeur Et De L'anxiété (Canmat) Concernant L'utilisation De La Kétamine Racémique Chez Les Adultes Souffrant De Trouble Dépressif MajeurJennifer Swainson, Alexander McGirr, Pierre Blier, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|August 17, 2022
The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive DisorderJoshua D Rosenblat, M Ishrat Husain, Yena Lee, et al.
Frontiers in Psychiatry|July 30, 2021
Prevalence and Risk Factors of Mental Health Symptoms and Suicidal Behavior Among University Students in Wuhan, China During the COVID-19 PandemicYingying Xu, Sizhen Su, Zhendong Jiang, et al.
Molecular Psychiatry|March 4, 2021
Peripheral inflammatory biomarkers define biotypes of bipolar depressionYena Lee, Rodrigo B Mansur, Elisa Brietzke, et al.
Bipolar Disorders|October 2, 2021
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) recommendations for the management of patients with bipolar disorder with mixed presentationsLakshmi N Yatham, Trisha Chakrabarty, David J Bond, et al.
Eclinicalmedicine|September 13, 2021
Mental and neurological disorders and risk of COVID-19 susceptibility, illness severity and mortality: A systematic review, meta-analysis and call for actionLin Liu, Shu-Yu Ni, Wei Yan, et al.
The Journal of Clinical Psychiatry|March 7, 2019
Symptomatic and Functional Outcomes and Early Prediction of Response to Escitalopram Monotherapy and Sequential Adjunctive Aripiprazole Therapy in Patients With Major Depressive Disorder: A CAN-BIND-1 ReportSidney H Kennedy, Raymond W Lam, Susan Rotzinger, et al.
BMC Psychiatry|April 17, 2016
Discovering biomarkers for antidepressant response: protocol from the Canadian biomarker integration network in depression (CAN-BIND) and clinical characteristics of the first patient cohortRaymond W Lam, Roumen Milev, Susan Rotzinger, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|February 12, 2025
Canadian Network for Mood and Anxiety Treatments 2024 Clinical Practice Guideline for the Management of Perinatal Mood, Anxiety, and Related Disorders: Guide de pratique 2024 du Canadian Network for Mood and Anxiety Treatments pour le traitement des troubles de l'humeur, des troubles anxieux et des troubles connexes périnatalsSimone N Vigod, Benicio N Frey, Crystal T Clark, et al.
Pageof 26

Showing results (241-250 of 252) with videos related to

Sort By:
Pageof 26
Psychological Medicine|November 5, 2020
Mental health services for infectious disease outbreaks including COVID-19: a rapid systematic reviewJing-Li Yue, Wei Yan, Yan-Kun Sun, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|November 11, 2020
The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Recommendations for the Use of Racemic Ketamine in Adults with Major Depressive Disorder: Recommandations Du Groupe De Travail Du Réseau Canadien Pour Les Traitements De L'humeur Et De L'anxiété (Canmat) Concernant L'utilisation De La Kétamine Racémique Chez Les Adultes Souffrant De Trouble Dépressif MajeurJennifer Swainson, Alexander McGirr, Pierre Blier, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|August 17, 2022
The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive DisorderJoshua D Rosenblat, M Ishrat Husain, Yena Lee, et al.
Frontiers in Psychiatry|July 30, 2021
Prevalence and Risk Factors of Mental Health Symptoms and Suicidal Behavior Among University Students in Wuhan, China During the COVID-19 PandemicYingying Xu, Sizhen Su, Zhendong Jiang, et al.
Molecular Psychiatry|March 4, 2021
Peripheral inflammatory biomarkers define biotypes of bipolar depressionYena Lee, Rodrigo B Mansur, Elisa Brietzke, et al.
Bipolar Disorders|October 2, 2021
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) recommendations for the management of patients with bipolar disorder with mixed presentationsLakshmi N Yatham, Trisha Chakrabarty, David J Bond, et al.
Eclinicalmedicine|September 13, 2021
Mental and neurological disorders and risk of COVID-19 susceptibility, illness severity and mortality: A systematic review, meta-analysis and call for actionLin Liu, Shu-Yu Ni, Wei Yan, et al.
The Journal of Clinical Psychiatry|March 7, 2019
Symptomatic and Functional Outcomes and Early Prediction of Response to Escitalopram Monotherapy and Sequential Adjunctive Aripiprazole Therapy in Patients With Major Depressive Disorder: A CAN-BIND-1 ReportSidney H Kennedy, Raymond W Lam, Susan Rotzinger, et al.
BMC Psychiatry|April 17, 2016
Discovering biomarkers for antidepressant response: protocol from the Canadian biomarker integration network in depression (CAN-BIND) and clinical characteristics of the first patient cohortRaymond W Lam, Roumen Milev, Susan Rotzinger, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|February 12, 2025
Canadian Network for Mood and Anxiety Treatments 2024 Clinical Practice Guideline for the Management of Perinatal Mood, Anxiety, and Related Disorders: Guide de pratique 2024 du Canadian Network for Mood and Anxiety Treatments pour le traitement des troubles de l'humeur, des troubles anxieux et des troubles connexes périnatalsSimone N Vigod, Benicio N Frey, Crystal T Clark, et al.
Pageof 26